Drugs / Tdap
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02301702 | Jul 2016 → Aug 2019 | pertussis | Emory University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02301702 ↗ |
| Modality | Vaccine | “randomized, blinded, controlled, vaccine trial” NCT02301702 ↗ |
| Route | Intramuscular | “0.5mL intramuscular injection” NCT02301702 ↗ |